Food Allergy Protocol

ImmuneEmerging Evidence

supplements

Primary

Supporting

Grade A

Studies

Primary Stack

Core supplements with strongest evidence

Probiotics (Lactobacillus rhamnosus GG)B

10-20 billion CFU daily

Modulates immune tolerance via Treg cell induction and reduces intestinal permeability

Allergic Disease Risk↓Eczema Symptoms

12 studies850 participants

Supporting Studies (1)

PMID: 26161688 - LGG with peanut OIT enhances tolerance (2015)

Supporting Stack

Additional supplements for enhanced results

Vitamin D3C

2000-4000 IU daily

Promotes immune tolerance and Treg development; deficiency linked to food allergy risk

6 studies320 participants

QuercetinC

500mg twice daily

Stabilizes mast cells, reducing histamine release during allergic reactions

3 studies80 participants

Omega-3 Fatty AcidsC

1-2g EPA/DHA daily

Reduces inflammatory response and may promote oral tolerance development

4 studies180 participants

How This Protocol Works

Simple Explanation

Food allergies involve the immune system mistakenly attacking harmless food proteins. These supplements support immune tolerance—the process by which the body learns to accept foods as safe.

•Lactobacillus rhamnosus GG is the most studied probiotic for food allergies. It helps develop regulatory T-cells (Tregs) that suppress allergic responses. When combined with oral immunotherapy (gradual exposure to allergens), it significantly improves outcomes.

•Vitamin D plays a crucial role in immune regulation. Children with vitamin D deficiency have higher rates of food allergies. Adequate D levels support the development of tolerance.

•Quercetin is a natural mast cell stabilizer—it helps prevent the release of histamine that causes allergic symptoms.

•Omega-3s shift the immune response away from allergic (Th2) pathways.

Important: These supplements do NOT replace allergen avoidance or treat anaphylaxis. They support immune tolerance development, often alongside medical treatments like oral immunotherapy (OIT).

Expected timeline: Immune modulation is gradual—expect 3-6 months for measurable changes in tolerance.

Clinical Perspective

IgE-mediated food allergy involves Th2-skewed immune response, allergen-specific IgE production, mast cell sensitization, and histamine release upon re-exposure. This protocol targets immune tolerance mechanisms.

•LGG (L. rhamnosus GG) (B-grade): Induces tolerogenic dendritic cells and Foxp3+ regulatory T-cells via TLR2 signaling. Enhances intestinal barrier function (increased tight junction proteins). Combined with peanut OIT, achieved sustained unresponsiveness in 82% vs 4% control (PMID: 26161688).

•Vitamin D3 (C-grade): VDR activation promotes Treg differentiation and suppresses Th2 cytokines (IL-4, IL-13). Epidemiological data: higher latitude and vitamin D deficiency associated with increased food allergy prevalence.

•Quercetin (C-grade): Inhibits IgE-mediated mast cell activation by blocking FcεRI signaling. Also inhibits IL-4 and IL-13 production by basophils.

•Omega-3 EPA/DHA (C-grade): Compete with arachidonic acid, reducing prostaglandin E2 and leukotriene B4 production. May promote shift from Th2 to Th1/Treg phenotype.

Biomarkers: Allergen-specific IgE, skin prick test wheal size, basophil activation test, serum vitamin D.

Clinical context: These supplements are adjunctive to medical management. Food OIT with probiotic co-administration shows enhanced efficacy. Always maintain emergency epinephrine access.

View All Protocols